NCT04704947

Clinical Study Evaluating Beta Blockers Use and Fracture Risk in Patients With Primary Osteoporosis

Clinical Study Evaluating Selective or Nonselective Beta Blockers Use and Fracture Risk in Patients With Primary Osteoporosis

• Status: Recruiting
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 50 (estimated)
• Sponsor: Sherief Abd-Elsalam · Academic / Other
• Sex: All
• Age: 50 Years
• Healthy volunteers: Not accepted

Summary

Clinical study evaluating selective or nonselective beta blockers use and fracture risk in patients with primary osteoporosis

Detailed description

Clinical study evaluating selective or nonselective beta blockers use and if there is fracture risk in patients with primary osteoporosis

Conditions

• Beta Blocker Toxicity

Interventions

Type	Name	Description
DRUG	nonselective beta blocker	nonselective beta blocker
DRUG	cardio-selective beta blocker group	cardio-selective beta blocker group
DRUG	alendronate sodium	alendronate sodium

Timeline

• Start date: 2017-10-01
• Primary completion: 2030-10-01
• Completion: 2030-10-01
• First posted: 2021-01-12
• Last updated: 2021-01-12

Locations

1 site across 1 country: Egypt